Correlation Between HUTCHMED DRC and Elevation Oncology
Can any of the company-specific risk be diversified away by investing in both HUTCHMED DRC and Elevation Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HUTCHMED DRC and Elevation Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HUTCHMED DRC and Elevation Oncology, you can compare the effects of market volatilities on HUTCHMED DRC and Elevation Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HUTCHMED DRC with a short position of Elevation Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of HUTCHMED DRC and Elevation Oncology.
Diversification Opportunities for HUTCHMED DRC and Elevation Oncology
-0.36 | Correlation Coefficient |
Very good diversification
The 3 months correlation between HUTCHMED and Elevation is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding HUTCHMED DRC and Elevation Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevation Oncology and HUTCHMED DRC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HUTCHMED DRC are associated (or correlated) with Elevation Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevation Oncology has no effect on the direction of HUTCHMED DRC i.e., HUTCHMED DRC and Elevation Oncology go up and down completely randomly.
Pair Corralation between HUTCHMED DRC and Elevation Oncology
Considering the 90-day investment horizon HUTCHMED DRC is expected to under-perform the Elevation Oncology. But the stock apears to be less risky and, when comparing its historical volatility, HUTCHMED DRC is 1.65 times less risky than Elevation Oncology. The stock trades about -0.07 of its potential returns per unit of risk. The Elevation Oncology is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest 52.00 in Elevation Oncology on September 3, 2024 and sell it today you would earn a total of 12.00 from holding Elevation Oncology or generate 23.08% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
HUTCHMED DRC vs. Elevation Oncology
Performance |
Timeline |
HUTCHMED DRC |
Elevation Oncology |
HUTCHMED DRC and Elevation Oncology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with HUTCHMED DRC and Elevation Oncology
The main advantage of trading using opposite HUTCHMED DRC and Elevation Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HUTCHMED DRC position performs unexpectedly, Elevation Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevation Oncology will offset losses from the drop in Elevation Oncology's long position.HUTCHMED DRC vs. Connect Biopharma Holdings | HUTCHMED DRC vs. Acumen Pharmaceuticals | HUTCHMED DRC vs. Nuvation Bio | HUTCHMED DRC vs. Eledon Pharmaceuticals |
Elevation Oncology vs. Ocean Biomedical | Elevation Oncology vs. Zura Bio Limited | Elevation Oncology vs. Enveric Biosciences | Elevation Oncology vs. Hepion Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |